Industrial Biotechnology Leadership Forum (IBLF)

The UK Government established the IBLF to provide a steering structure and governance body to assess progress, update recommendations and shape priorities for the growth of the UK’s bioeconomy.

IBLF provides a visible point for strategic coordination between industry (from large corporates to SMEs), the research community, public access scale-up facilities, funding agencies, government and other key stakeholders.

Secretariat of the IBLF is provided by Innovate UK Business Connect: for more information on our work in biotechnology, click here.

Why is Industrial Biotechnology important?

To achieve the UK government’s ambitious net-zero by 2050 goal, progress is required across all sectors of the economy. Harnessing nature and biologically derived products and processes is crucial to providing significant societal and economic benefits alongside reducing carbon emissions.

There are four key pillars underpinning Industrial Biotechnology:

1. Bio-based raw material inputs often instead of the use of oil and gas.
2. Cells and plants as biological factories.
3. Enzymes as incredible specific catalysts in the industrial processes of the future.
4. The Microbiome, harnessing micro-organisms in end-uses such as the improvement of human gut health.

The shift towards the Industrial Biotechnology revolution is being accelerated by the ground breaking technology of Engineering Biology(EB) which sits at the convergence of genomics, data science and other disciplines. EB has benefitted from significant increases in computing power, the growing capabilities of machine learning and AI, and the decreasing cost of DNA synthesis and sequencing.

This technology is already delivering robust and resilient clean economic growth across many applications and is contributing to UK policies including Net Zero, moving to a circular economy and improving biodiversity. It already provides low-cost biofuels, superior vaccines, diagnostic tools, renewable chemicals, biodegradable materials, high yielding pest-resistant crops, low impact crop protection and novel foods including meat substitutes. This progress provides a foundation to deliver robust and resilient economic growth whilst achieving Net Zero.

Who is part of the Industrial Biotechnology Leadership Forum?

The Industrial Biotechnology Leadership Forum (IBLF) is jointly chaired by Paul Mines (interim). The Secretariat is provided by a member of Innovate UK Business Connect’s Industrial Biotechnology team (currently Dana Heldt).

Membership of the IBLF is reviewed annually. Stakeholders from the community who wish to be considered should make their interest known to the Secretariat.

Members of the IBLF include:
Anke Davis – EPSRC
Adrian Higson – NNFCC
Andrew Ellis – Biocatalysts Ltd
Andrew Hagan – World Council on IB
Colin Miles – BBSRC
Damian Kelly – Croda
Dana Heldt – Innovate UK Business Connect
Darren Budd – BASF
Edward Green – NCIMB, BIA EBAC
Ivey Geoghegan – Quorn Foods
Izzy Webb – DSIT
Jack Weaver – DSIT
Jen Vanderhoven – BBIA
Jeremy Bartosiak-Jentys – Supplant
John Barratt – Stellar Robotics, Consultant
John Williams – AquaPak and S’Investec
Jonathan Runnacles – Mitsubishi Chemical Methacrylates
Justine Fosh – Cogent Skills
Kris Wadrop – CPI
Mark Bustard – IBioIC
Mark Corbett – BDC
Mary Jenkinson-Finch – BBSRC
Matthew Bycroft – Dr Reddys
Matthew Hodges – HydRegen
Neil Parry – Unilever
Paul Bello – Innovate UK
Paul Mines (IBLF chair) – Biome Bioplastics
Reuben Carr – Ingenza
Richard Lock – Holiferm
Sara Holland – Potter Clarkson
Steve Bagshaw – HVM Catapult
Tim Davies – Corteva
Will Barton – HydRegen